Cian Healthcare Balance Sheet Annual

BSE: 542678 | NSE: - | ISIN: INE05BN01019 | Sector: Biotechnology & Drugs

4.14 +0.01 (0.24%)Updated : 24 Jun 2025

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	1.19	1.33	1.34	2.32
Cashand Short Term Investments	1.19	1.33	1.34	2.32
Accounts Receivable- Trade Net	20.48	26.23	26.72	18.90
Total Receivables Net	26.06	31.92	34.27	30.27
Total Inventory	40.93	36.64	39.37	30.73
Other Current Assets Total	3.56	4.35	3.97	0.01
Total Current Assets	71.74	74.24	78.96	63.37
Property/ Plant/ Equipment Total- Net	53.98	58.47	62.58	62.47
Long Term Investments	4.89	4.89	4.89	4.89
Note Receivable- Long Term	11.27	10.69	14.43	20.05
Other Long Term Assets Total	19.29	12.18	5.08	6.48
Total Assets	161.18	160.48	165.94	157.25
Accounts Payable	31.27	27.10	35.50	20.57
Accrued Expenses	0.00	0.15	0.10	1.01
Notes Payable/ Short Term Debt	21.60	21.44	21.12	21.50
Current Portof LT Debt/ Capital Leases	6.60	9.85	3.70	11.20
Other Currentliabilities Total	6.65	6.74	9.04	3.50
Total Current Liabilities	66.11	65.27	69.45	57.79
Long Term Debt	27.33	29.06	37.77	37.15
Capital Lease Obligations	0.17	0.32	0.37	0.50
Total Long Term Debt	27.50	29.38	38.13	37.64
Total Debt	55.69	60.67	62.95	70.34
Deferred Income Tax	1.10	1.13	1.50	1.97
Other Liabilities Total	8.72	7.22	1.40	1.61
Total Liabilities	103.44	102.99	110.48	99.01
Common Stock Total	25.00	25.00	25.00	23.36
Retained Earnings( Accumulated Deficit)	32.74	32.49	-8.30	-2.73
Total Equity	57.74	57.49	55.46	58.24
Total Liabilities Shareholders' Equity	161.18	160.48	165.94	157.25
Total Common Shares Outstanding	2.50	2.50	2.50	2.34
Tangible Book Valueper Share Common Eq	23.10	23.00	22.19	24.93
period Length	0.00	0.00	0.00	0.00
Additional Paid- In Capital	-	-	38.76	37.61
Prepaid Expenses	-	-	-	0.04
Property/ Plant/ Equipment Total- Gross	-	-	-	51.79
Accumulated Depreciation Total	-	-	-	-15.26
Intangibles Net	-	-	-	0.00